BBA
TIL icon

Baker Bros. Advisors’s Instil Bio TIL Stock Holding History

Baker Bros. Advisors’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-235,220
Closed -$2.01M – 100
2023
Q3 		$2.01M Sell
235,220
-28,469
-11% -$287K 0.01% 86
2023
Q2 		$2.91M Hold
263,689
– – 0.02% 88
2023
Q1 		$3.48M Hold
263,689
– – 0.02% 78
2022
Q4 		$3.32M Buy
263,689
+69,004
+35% +$3.41M 0.02% 86
2022
Q3 		$18.8M Hold
194,685
– – 0.12% 48
2022
Q2 		$18M Hold
194,685
– – 0.1% 50
2022
Q1 		$41.9M Hold
194,685
– – 0.24% 32
2021
Q4 		$66.6M Hold
194,685
– – 0.32% 27
2021
Q3 		$69.6M Hold
194,685
– – 0.31% 27
2021
Q2 		$75.2M Hold
194,685
– – 0.33% 29
2021
Q1 		$97.7M Buy
+194,685
New +$99.9M 0.42% 21

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baker Bros. Advisors's TIL Position: Q4 2023 in Review

Baker Bros. Advisors sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 235,220 shares — an estimated $2.01M sold.

Baker Bros. Advisors first reported a position in TIL in Q1 2021 and held it in 11 quarters. The position peaked at $97.7M in Q1 2021. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

  • Baker Bros. Advisors reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
  • Baker Bros. Advisors sold 235,220 Instil Bio shares in Q4 2023, an estimated $2.01M.
  • Baker Bros. Advisors first reported a position in Instil Bio in Q1 2021 and held it in 11 quarters.
  • Baker Bros. Advisors's Instil Bio position peaked at $97.7M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Baker Bros. Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.